Moderate Calcific Aortic Valve Stenosis Cavs clinical trials

Explore recruiting moderate calcific aortic valve stenosis cavs clinical trials.

Recruiting moderate calcific aortic valve stenosis cavs studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Moderate Calcific Aortic Valve Stenosis Cavs trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2b/3, Randomized, Double-Blinded, Placebo Controlled Study ChecKing the Efficacy and Safety of ATAciguat to Slow the Progression of VaLvular DYsfunction in Participants with Moderate Calcific Aortic Valve STenosis (KATALYST-AV)

Norway, Czechia, Portugal, Austria, Poland, France +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Moderate Calcific Aortic Valve Stenosis Cavs trials by city

Moderate Calcific Aortic Valve Stenosis Cavs in Toronto Moderate Calcific Aortic Valve Stenosis Cavs in Vancouver Moderate Calcific Aortic Valve Stenosis Cavs in Montreal Moderate Calcific Aortic Valve Stenosis Cavs in Calgary Moderate Calcific Aortic Valve Stenosis Cavs in Edmonton Moderate Calcific Aortic Valve Stenosis Cavs in Ottawa Moderate Calcific Aortic Valve Stenosis Cavs in Winnipeg Moderate Calcific Aortic Valve Stenosis Cavs in Quebec City Moderate Calcific Aortic Valve Stenosis Cavs in Hamilton Moderate Calcific Aortic Valve Stenosis Cavs in Kitchener Moderate Calcific Aortic Valve Stenosis Cavs in London Moderate Calcific Aortic Valve Stenosis Cavs in Halifax Moderate Calcific Aortic Valve Stenosis Cavs in New York Moderate Calcific Aortic Valve Stenosis Cavs in Los Angeles Moderate Calcific Aortic Valve Stenosis Cavs in Chicago Moderate Calcific Aortic Valve Stenosis Cavs in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease